Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B

FEMS Immunology and Medical Microbiology

Volumn 61, Issue 2, 2011, Pages 197-204

  Clark, Jason R ^a   Bartley, Kathryn ^b   Jepson, Catherine D ^b   Craik, Vicki ^a   March, John B ^a  

^a BigDNA Ltd   (United Kingdom)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Bacteriophage; HBsAg; Hepatitis; Lambda; Nanoparticles; Vaccine

Indexed keywords

ANTIBODY; DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIOPHAGE; BACTERIOPHAGE LAMBDA; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENT; HEPATITIS B; IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RABBIT; SURFACE PROPERTY; TEMPERATURE; VACCINATION;

ANIMALS; BACTERIOPHAGE LAMBDA; CELL PROLIFERATION; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; IMMUNIZATION, SECONDARY; LYMPHOCYTES; RABBITS; RECOMBINANT PROTEINS; VACCINATION; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 79951512923     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00763.x     Document Type: Article

References (35)

1. Abdulhaqq SA & Weiner DB (2008) DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 42: 219-232.
2. Andersson J, Sjöberg O & Möller G (1972) Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol 2: 349-353.
3. Block TM, Guo H & Guo JT (2007) Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis 11: 685-706, vii.
4. British Medical Association (2010) Web Site Available at
5. Clark JR & March JB (2004a) Bacterial viruses as human vaccines? Expert Rev Vaccines 3: 463-476.
6. Clark JR & March JB (2004b) Bacteriophage-mediated nucleic acid immunisation. FEMS Immunol Med Mic 40: 21-26.
7. Davis HL, Michel ML & Whalen RG (1993) DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 2: 1847-1851.
8. Davis HL, Schirmbeck R, Reimann J & Whalen RG (1995) DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 6: 1447-1456.
9. El-Sayed B, El-Guindi M, El-Shaarawy A, Salama EI & Sobhy GA (2009) Long-term immunogenicity of hepatitis B vaccination in children. Zagazig J Occup Health Safety 2: 17-28.
10. Ghaemi A, Soleimanjahi H, Gill P, Hassan Z, Jahromi SRM & Roohvand F (2010) Recombinant λ-phage nanobioparticles for tumor therapy in mice models. Genet Vaccines Ther 8: 3-9.
11. Gorski A, Dabrowska K, Switala-Jelen K, Nowaczyk M, Weber-Dabrowska B, Boratynski J, Wietrzyk J & Opolski A (2003) New insights into the possible role of bacteriophages in host defense and disease. Med Immunol 2: 2-9.
12. Hashemi H, Bamdad T, Jamali A, Pouyanfard S & Mohammadi MG (2010) Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine. J Virol Methods 163: 440-444.
13. Jepson CD & March JB (2004) Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 22: 2413-2419.
14. Jilg W, Schmidt M & Deinhardt F (1988) Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 6: 201-207.
15. Jilg W, Schmidt M & Deinhardt F (1989) Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis 160: 766-769.
16. Kleinschmidt WJ, Douthart RJ & Murphy EB (1970) Interferon production by T4 coliphage. Nature 228: 27-30.
17. Klinman DM (2003) CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2: 305-315.
18. Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis 11: 97-107.
19. Lemieux P (2002) Technological advances to increase immunogenicity of DNA vaccines. Expert Rev Vaccines 1: 85-93.
20. Liang H, Nishioka Y, Reich CF, Pisetsky DS & Lipsky PE (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 98: 1119-1129.
21. Liu MA & Ulmer JB (2005) Human clinical trials of plasmid DNA vaccines. Adv Genet 55: 25-40.
22. Mahoney FJ (1999) Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 12: 351-366.
23. Malanchèrè-Brès E, Payette PJ, Mancini M, Tiollais P, Davis HL & Michel M-L (2001) CpG oligonucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice. J Virol 75: 6482-6491.
24. March JB, Clark JR & Jepson CD (2004) Genetic immunisation against hepatitis B using whole bacteriophage lambda particles. Vaccine 22: 1666-1671.
25. March JB, Jepson CD, Clark JR, Totsika M & Calcutt MJ (2006) Phage library screening for the rapid identification and in vivo testing of candidate genes for a DNA vaccine against Mycoplasma mycoides subsp. mycoides small colony biotype. Infect Immun 74: 167-174.
26. Miedzybrodzki R, Fortuna W, Weber-Dabrowska B & Gorski A (2005) Bacterial viruses against viruses pathogenic for man? Virus Res 110: 1-8.
27. Murray NE, Brammar WJ & Murray K (1977) Lambdoid phages that simplify the recovery of in vitro recombinants. Mol Gen Genet 150: 53-61.
28. Plotkin SA (2010) Correlates of protection induced by vaccination. Clin Vaccine Immunol 17: 1055-1065.
29. Schirmbeck R, Bohm W, Ando K, Chisari FV & Reimann J (1995) Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 69: 5929-5934.
30. Sjogren MH (2005) Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med 118 (suppl 10A): 34S-39S.
31. Sonveaux N, Thines D & Ruysschaert JM (1995) Characterization of the HBsAg particle lipid membrane. Res Virology 146: 43-51.
32. World Health Organisation (2000) Hepatitis B. Fact Sheet 204. World Health Organisation, Geneva.
33. World Health Organisation (2002) Web Site Available at
34. Young RA & Davies RW (1983) Efficient isolation of genes by using antibody probes. P Natl Acad Sci USA 80: 1194-1198.
35. Yu AS, Cheung RC & Keeffe EB (2004) Hepatitis B vaccines. Clin Liver Dis 8: 283-300.